Duopharma Biotech Berhad (KLSE:DPHARMA)

Market Cap	1.28B +5.6%
Revenue (ttm)	900.68M +14.4%
Net Income	83.50M +48.9%
EPS	0.09 +49.1%
Shares Out	961.94M
PE Ratio	15.32
Forward PE	12.85
Dividend	0.03 (2.17%)
Ex-Dividend Date	Sep 8, 2025

Volume	618,200
Average Volume	765,325
Open	1.380
Previous Close	1.380
Day's Range	1.330 - 1.380
52-Week Range	1.070 - 1.460
Beta	0.37
RSI	61.22
Earnings Date	Feb 19, 2026

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides sp...

• Industry: Pharmaceutical Preparations
• Founded: 1978
• Employees: 1,957
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DPHARMA

Financial Performance

In 2024, Duopharma Biotech Berhad's revenue was 813.70 million, an increase of 15.46% compared to the previous year's 704.73 million. Earnings were 62.65 million, an increase of 19.00%.